Decleire Nephro SRL
Decleire Nephro reported total assets of 444,008 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Decleire Nephro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +91 % Total assets +14 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decleire Nephro's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 64,063 € | ||||
| Equity | 358,788 € | ||||
| Cash | 323,194 € | ||||
| EBITDA | 128,581 € | ||||
| Total assets | 444,008 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 02 Aug 2023
- Year ended 31 Dec 2021filed on 26 Oct 2022
Decleire Nephro's financial analysis
- Solvency80.8%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decleire Nephro
Decleire Nephro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0747.739.148
- VAT number
- BE0747739148
- Peppol
- Registered · 0208:0747739148 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 May 2020
- Registered office
- 6700 Arlon
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Decleire Nephro (SRL) has been based in Arlon since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 64,063 € and equity of 358,788 €; its revenue is not published. Its solvency stands at 80.8%, above the median of its sector (65.0%).
Companies similar to Decleire Nephro
Companies in the same business, of comparable size and area, outside its group.
- Ciarafoni Deborah Medical specialists activities Fleurus · balance sheet 440,490 €
- V. IDE. OR Medical specialists activities Mons · balance sheet 447,989 €
- Dr Debouck Catherine Medical specialists activities Linkebeek · balance sheet 443,969 €
- Dr. Sofie Ghekiere - Oftalmologie Medical specialists activities Ypres · balance sheet 444,259 €
- DR. Nijs Jochen Medical specialists activities Sint-Truiden · balance sheet 444,259 €
- Dr. Cedric Moerman Medical specialists activities Kontich · balance sheet 444,493 €
- Lsane Medical specialists activities Kortrijk · balance sheet 443,488 €
- Anesthésie-Réanimation / Soins Intensifs Docteur Damien Henrard Medical specialists activities Wasseiges · balance sheet 444,719 €
Frequently asked questions about Decleire Nephro
What is the revenue of Decleire Nephro?
Decleire Nephro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Decleire Nephro?
In Belgium, the VAT number is the company number prefixed with BE: BE0747739148 for Decleire Nephro, if the company is VAT-registered. Its company number (CBE) is 0747.739.148.
Where is the registered office of Decleire Nephro?
According to the CBE register, the registered office of Decleire Nephro is in 6700 Arlon.
What is the equity of Decleire Nephro?
At the close of the 2025 financial year, the equity of Decleire Nephro amounts to 358,788 €, a solvency of 80.8% of total assets.
Who manages Decleire Nephro?
The register lists 1 active mandates at Decleire Nephro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decleire Nephro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →